No Data
No Data
Weibo-SW (9898.HK): 4Q24 performance review AI efficiency improvements are starting to show, but observation of traffic growth and recovery of advertising demand is still necessary.
The core view in the preliminary guidance for 2025 is that the profit margin expectation is conservative (30% Non-GAAP OPM), the growth rate guidance is generally reasonable, and the key variables for 2025 are 1) AI efficiency improvement; 2) channel customer acquisition strategy.
Shares of US-listed Chinese Companies Are Trading Lower After the People's Bank of China Kept the One-year Loan Prime Rate at 3.1% and the Five-year Rate at 3.6%, as Policymakers Navigate Supporting Economic Growth While Stabilizing the Yuan Amid...
US stock movement | Weibo fell over 1% in pre-market trading, affected by institutions lowering earnings estimates and Target Price.
On March 20, Gelonghui reported that Weibo (WB.US) fell 1.87% in pre-market trading, at $10.5. CMB International issued a Research Report stating that Weibo's net revenue for the fourth quarter of the 2024 fiscal year remained basically flat year-on-year at fixed exchange rates, in line with market expectations; non-GAAP net profit increased by 40% year-on-year, 9% higher than market expectations, mainly due to effective control of operating expenses. Due to weak revenue outlook and AI investments, the bank has lowered Weibo's profit forecast for the 2025 to 2026 fiscal year by 3% to 5%, and the target price for US stocks has been reduced from $15 to $14.5, maintaining a "Buy" rating. (Gelonghui)
"New Stocks" Zhuozheng Medical applies to go public in Hong Kong again, Tencent (00700.HK) holds nearly 20%, and the CEO of Weibo (09898.HK) serves as an independent director.
The mainland private Medical Institutions, Chuo Zheng Medical, once again applied for a listing in Hong Kong after the invalidation of its application last May. According to preliminary prospectus documents, Tencent (00700.HK) invested through a subsidiary with an equity stake of 19.39% since August 2021. Additionally, Weibo-SW (09898.HK) CEO Wang Gaofei was appointed as an independent non-executive Director in April last year.
Citi has lowered the Target Price for Weibo (WB.US) to $14.5 and revised down the earnings forecast for this year and next.
CMB International published a Research Report indicating that Weibo (WB.US) is expected to have net revenue for the fourth quarter of the fiscal year 2024 remaining stable year-on-year when calculated at fixed Exchange Rates, in line with market expectations; non-GAAP net profit is expected to increase by 40% year-on-year, exceeding market expectations by 9%, mainly due to effective control of operating expenses. CMB International predicts that total revenue for Weibo in fiscal year 2025 will increase by 2% year-on-year when calculated at fixed Exchange Rates; non-GAAP operating profit margin will decline to 31% (fiscal year 2024: 33%). Due to weak revenue expectations and investments in AI, the bank has lowered the profit forecast for Weibo for fiscal years 2025 to 2026 by 3% to 5%.
Weibo To Go Ex-Dividend On April 9th, 2025 With 0.82 USD Dividend Per Share
March 17th (Eastern Time) - $Weibo(WB.US)$ is trading ex-dividend on April 9th, 2025.Shareholders of record on April 9th, 2025 will receive 0.82 USD dividend per share on May 15th, 2025. The ex-